BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 2 hours ago Valaris Limited Drops 6.7% in Broad Selloff 3 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 3 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 3 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 4 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 4 hours ago Celanese Corporation Shares Dropping 5.5% 4 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 4 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 4 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 4 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 2 hours ago Valaris Limited Drops 6.7% in Broad Selloff 3 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 3 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 3 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 4 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 4 hours ago Celanese Corporation Shares Dropping 5.5% 4 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 4 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 4 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 4 hours ago
ADVERTISEMENT
Market News

Wall St hits bulls-eye with Colgate-Palmolive Q2 estimates

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections. Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion. Earnings, on an […]

July 26, 2019 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections. Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion. Earnings, on an […]

Consumer goods company Colgate-Palmolive (NYSE: CL) on Friday reported second-quarter results that were in line with the Wall Street projections.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs, as well as currency headwinds. Analysts had projected Q2 revenues of $3.88 billion.

Earnings, on an adjusted basis, fell 6% to 72 cents per share, in line with the street estimates.

Q2 revenues of $3.87 billion, which were almost flat year-over-year, were hurt by higher raw material and advertising costs,

Colgate stock gained 1% following the announcement of the results. CL shares have gained 22% so far this year.

READ: Alphabet reverses ad revenue deceleration trend in Q2, stock rises

In North America, despite revenues increasing 2.5% year-over-year,
operating profits were down 4%. This was primarily due to higher raw and
packaging material costs, partially offset by cost savings from the company’s
funding-the-growth initiatives.

CEO Noel Wallace said, “Colgate’s leadership of the global toothpaste market continued during the quarter with our global market share at 41.4% year to date. Our global leadership in manual toothbrushes also continued with Colgate’s global market share in that category at 31.7% year to date.”

Outlook

The
company continues to expect 2019 net sales to be flat to up low-single-digits,
with organic sales up between 2% and 4%.

Excluding certain one-time costs, Colgate continue to plan for a year of
gross margin expansion, increased advertising investment and a mid-single-digit
decline in earnings per share.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT